Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Clinical trial NCT01459081 · COMPLETED

Trial details

NCT number: NCT01459081
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza A Virus Infection Influenza B Virus Infection

Start date: 2011-10-01
Primary completion: 2012-12-01
Enrollment: 298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.